Market Overview

UPDATE: JP Morgan Raises PT to $62 on Health Care REIT Post Q2

Share:
Related HCN
Earnings Scheduled For July 28, 2017
4 Big Dividend Stocks To Avoid In A Rising Interest Rate Environment

JP Morgan reiterated its Overweight rating on Health Care REIT (NYSE: HCN) and increased its price target from $61 to $62.

JP Morgan commented, "Our OW rating on HCN is based on a number of factors including our belief that the stock has above-average growth prospects relative to the health care sector, and we see valuation attractive based on discounted trading multiples and an above-average dividend yield."

Health Care REIT closed at $60.17 on Thursday.

Latest Ratings for HCN

DateFirmActionFromTo
Sep 2017Bank of AmericaMaintainsNeutral
Apr 2017Evercore ISI GroupDowngradesIn-LineUnderperform
Mar 2017Morgan StanleyUpgradesEqual-WeightOverweight

View More Analyst Ratings for HCN
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Reiteration Intraday Update Analyst Ratings

 

Related Articles (HCN)

View Comments and Join the Discussion!
Loading...
Loading...